advanced microbiome therapeutics
Showing 9976 - 10000 of >10,000
Non Small Cell Lung Cancer Trial in Shijiazhuang, Hohhot, Tianjin (Anlotinib Plus Icotinib)
Completed
- Non Small Cell Lung Cancer
- Anlotinib Plus Icotinib
-
Shijiazhuang, Hebei, China
- +4 more
Mar 11, 2021
Retinoblastoma, Extraocular Trial in Shanghai (Melphalan)
Recruiting
- Retinoblastoma, Extraocular
-
Shanghai, ChinaFudan Eye & ENT Hospital
Aug 26, 2021
Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-295S1 with dose escalation stage of 5mg up to 200mg, then expansion
Recruiting
- Advanced Malignant Solid Tumors
- HMPL-295S1 with dose escalation stage of 5mg up to 200mg, then expansion stage with recommended dose of therapeutic cycle of 28 days .
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 30, 2021
Solid Tumors Trial in Worldwide (Cobimetinib, Atezolizumab, Atezolizumab Cohort 7)
ctDNA Methylation for Detecting Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- +8 more
- Methylation assay
-
Beijing, Beijing, ChinaLei Li
Mar 24, 2023
Assessment of Portal Hypertension With Multiparametric MRI
Enrolling by invitation
- Portal Hypertension
- Clinically Significant Portal Hypertension
- mpMRI
- ARFI US
-
New York, New YorkMount Sinai Medical Center
Dec 17, 2021
Congenital Diaphragmatic Hernia Trial in Graz (initial VOC, initial fecal microbiome, initial pulmonary microbiome)
Completed
- Congenital Diaphragmatic Hernia
- initial VOC
- +8 more
-
Graz, Steiermark, AustriaDepartment of Department of Pediatric and Adolescent Surgery, Me
Apr 26, 2020
Cervical Cancer Trial in Hangzhou (compound kushen injection combined with pabolizumab)
Not yet recruiting
- Cervical Cancer
- compound kushen injection combined with pabolizumab
-
Hangzhou, Zhejiang, ChinaLili Chen
Mar 8, 2022
Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,
Recruiting
- Advanced Renal Cell Carcinoma
- +8 more
- Cabozantinib S-malate
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 24, 2023
Upper Limb Amputees Trial in Cleveland (Chronically Implanted Neural and Muscular Interface)
Recruiting
- Upper Limb Amputees
- Chronically Implanted Neural and Muscular Interface
-
Cleveland, OhioLouis Stokes VA Medical Center, Cleveland, OH
Feb 10, 2022
Acute Heart Failure, Cardiac Decompensation, Volume Overload Trial in Germany, Sweden, Switzerland (periph. minimal invasive
Terminated
- Acute Heart Failure
- +2 more
- periph. minimal invasive ultrafiltration
-
Heidelberg, Baden Württemberg, Germany
- +18 more
Jul 12, 2021
Substance-Related Disorders Trial in Almería (tDCS - tDCS, tDCS - Sham, Sham - tDCS)
Enrolling by invitation
- Substance-Related Disorders
- tDCS - tDCS
- +3 more
-
Almería, SpainPsychobiology Lab
Apr 26, 2022
Consciousness Disorder, Brain Injuries, Vegetative State Trial in Birmingham, London (Transcranial direct current stimulation)
Not yet recruiting
- Consciousness Disorder
- +3 more
- Transcranial direct current stimulation
-
Birmingham, West Midlands, United Kingdom
- +1 more
Apr 30, 2021
NSCLC (NSCLC) Trial in Baltimore ([18F]F-AraG Injection)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- [18F]F-AraG Injection
-
Baltimore, MarylandJohns Hopkins University
Dec 14, 2021
Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,
Active, not recruiting
- Advanced Malignant Neoplasm
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 21, 2022
Ultrasound Multimodal Imaging in Evaluation of Heart
Not yet recruiting
- Heart Transplant
- (no location specified)
Jul 13, 2021
CAR, Solid Tumor Trial in Hefei (Targeting CD276 autologous chimeric antigen receptor T cells)
Recruiting
- CAR
- Solid Tumor
- Targeting CD276 autologous chimeric antigen receptor T cells
-
Hefei, Anhui, ChinaBin Hu Hospital
Dec 28, 2020
COVID-19 Vaccination and Prevalence of COVID-19 in Chronic Liver
Not yet recruiting
- Chronic or Recovered Hepatitis B
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hepatocellular Carcinoma Trial in Worldwide (Pembrolizumab, Regorafenib (Stivarga, BAY73-4506))
Active, not recruiting
- Hepatocellular Carcinoma
- Pembrolizumab
- Regorafenib (Stivarga, BAY73-4506)
-
Tucson, Arizona
- +38 more
Aug 1, 2022
Faecal Analyses in Spondyloarthritis Therapy
Unknown status
- Spondyloarthropathies
- Ankylosing Spondylitis
-
Lund, SwedenReumatologi SUS Lund, Region Skåne
Mar 18, 2020
Colorectal Cancer Early Screening in China
Completed
- Colorectal Cancer
- +3 more
- Multitarget stool FIT-DNA test - ColoClear
- +2 more
-
Zhengzhou, Henan, China
- +7 more
Dec 7, 2020